§ 13F · FUND PROFILE
ORBIMED ADVISORS LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 108Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$4899.4T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | EWTX | EDGEWISE THERAPEUTICS INC | 15.52M | $385.1T | 7.9% | NEW |
| 2 | LLY | ELI LILLY & CO | 301K | $323.7T | 6.6% | NEW |
| 3 | BSX | BOSTON SCIENTIFIC CORP | 2.42M | $230.7T | 4.7% | NEW |
| 4 | SVA | SINOVAC BIOTECH LTD | 2.72M | $184.5T | 3.8% | NEW |
| 5 | EW | EDWARDS LIFESCIENCES CORP | 1.84M | $157.1T | 3.2% | NEW |
| 6 | UPB | UPSTREAM BIO INC | 5.69M | $154.6T | 3.2% | NEW |
| 7 | ISRG | INTUITIVE SURGICAL INC | 263K | $149.2T | 3.0% | NEW |
| 8 | SION | SIONNA THERAPEUTICS INC | 3.56M | $146.5T | 3.0% | NEW |
| 9 | MBX | MBX BIOSCIENCES INC | 3.94M | $124.1T | 2.5% | NEW |
| 10 | ARGX | ARGENX SE | 146K | $122.8T | 2.5% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ORBIMED SIGNAL
AC read
ORBIMED ADVISORS LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed